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a b s t r a c t
The parvovirus minute virus of mice, prototype strain (MVMp), preferentially infects and kills cancer
cells. This intrinsic MVMp oncotropism may depend in part on the early stages of MVMp infection.
To test this hypothesis, we investigated the early events of MVMp infection in mouse LA9 ﬁbroblasts and
a highly invasive mouse mammary tumor cell line derived from polyomavirus middle T antigen-mediated
transformation. Using a combination of ﬂuorescence and electron microscopy, we found that various
parameters of the cell migration process affect MVMp infection. We show that, after binding to the plasma
membrane, MVMp particles rapidly cluster at the leading edge of migrating cells, which exhibit higher
levels of MVMp uptake than non-motile cells. Moreover, promoting cell migration on a ﬁbronectin matrix
increased MVMp infection, and induction of epithelial–mesenchymal transition allowed MVMp replication
in non-permissive epithelial cells. Hence, we propose that cell migration inﬂuences the early stages of
MVMp infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The minute virus of mice (MVM) is a small (26 nm in diameter),
non-enveloped, single-stranded DNA virus that belongs to the
family Parvoviridae (Cotmore et al., 2014). The MVM genome of
5-kb carries only two open reading frames: the “right” (50) codes
for the two capsid proteins VP1 and VP2, while the “left” (30) codes
for the two non-structural proteins, NS1 and NS2 (Berns, 1990).
MVM exists in two variant forms: MVMp, which is the prototype
strain (Crawford, 1966), infects cells of ﬁbroblast origin, and MVMi,
the immunosuppressive strain, infects T lymphocytes (Bonnard
et al., 1976). MVMp, unlike MVMi, is harmless to adult mice, and
selectively infects cancer cells (Mousset and Rommelaere, 1982;
Rommelaere et al., 2010). This property of MVMp, also known as
oncotropism/oncolytism, together with the apathogenicity of
MVMp to humans, has presented the exciting possibility of using
MVMp in anti‐cancer therapy.
Several studies have attempted to explain why MVMp prefer-
entially targets rapidly dividing cancer cells (reviewed by Nuesch
et al. (2012)), and several determinants for MVMp oncotropism
have been proposed. First, because MVMp replication depends on
host cell factors that are present during the S phase of the cell
cycle (reviewed by Cotmore and Tattersall (2006)), the viral DNA
replicates more easily in rapidly dividing cancer cells, which
escape growth control. For example, conversion of the viral
single-stranded DNA to double-stranded DNA depends on cyclin
A and cyclin A-associated kinase activity (Bashir et al., 2000);
subsequent transcription of the double-stranded DNA depends on
the host transcription factors E2F and CREB/ATF (Burnett and
Tattersall, 2003; Deleu et al., 1999; Paglino et al., 2007), which
become available during the S-phase and which are also deregu-
lated in cancer. Second, MVMp oncotropism has also been attrib-
uted to the posttranslational modiﬁcation of parvoviral and
cellular proteins by cellular kinases that are overexpressed or
altered in cancer cells. For example, trimers of the capsid protein
VP2 undergo phosphorylation by Raf-1 kinase (Riolobos et al.,
2010); this phosphorylation regulates the nuclear transport of the
VP2 trimers for subsequent assembly of progeny viral capsids in
the nucleus (Riolobos et al., 2010). Similarly, phosphorylation of
NS1, which controls the activity of this protein during both viral
DNA replication and transcription, and phosphorylation of the
eukaryotic translation initiation factor 2 subunit 1 (eIF2α) by
protein kinase R have been proposed to contribute to MVMp
oncotropism (Nuesch et al., 2012; Ventoso et al., 2010). Finally, it
has been proposed that the failure of cancer cells to mount an
antiviral response mechanism contributes in part to MVMp
oncotropism. This is supported by the ﬁnding that MVMp infection
of normal, but not transformed, mouse embryonic ﬁbroblasts
induces the production of type I interferons (IFNs) (Grekova
et al., 2010; Mattei et al., 2013). However, MVMp replication is
unaffected by MVMp-induced IFNs or treatment of cells with IFNs
(Mattei et al., 2013; Paglino et al., 2014). Moreover, the MVMp-
induced activation of the type I IFN anti-viral response is cell-
dependent, and does not occur in human normal or cancer cells
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(Paglino et al., 2014). Thus, the involvement of the IFN anti-viral
response in MVMp oncotropism has not been well established.
All these studies have indicated that MVMp oncotropism is
mediated on several levels of the viral infection cycle. However, to
date there has been no indication of whether the molecular
mechanisms regulating MVMp oncotropism could also be regulated
at earlier stages during the MVMp infection cycle. Since several
types of aggressive tumor cells exhibit increased migration, which
depends on the uptake and degradation of cell surface receptors
(Nagano et al., 2012), we hypothesized that MVMp, and other
oncotropic viruses, take advantage of some aspects of the cell
migration machinery in order to preferentially infect highly meta-
static/invasive cancer cells. In support of this hypothesis, the cells
commonly used for studies of MVMp infection and cell migration
are ﬁbroblasts. Furthermore, Linser et al. (1977) have shown by
electron microscopy (EM) that MVMp particles cluster around
cellular ﬁlopodia immediately prior to endocytosis in mouse LA9
ﬁbroblasts, indicating that the entry of MVMp into the cell could
occur at the leading edge of migrating ﬁbroblasts.
During cell migration, many cellular components are involved in
the complex interactions that connect the extra-cellular matrix
(ECM) to the cytoskeleton via trans-membrane receptors. For
example, it is now well established that α5β1-integrins bind to
the ECM protein ﬁbronectin (FN) to form focal adhesion complexes
at the leading edge of migrating cells (Burridge et al., 1997;Wu et al.,
1993). This allows recruitment of numerous cellular proteins to the
cytoplasmic tail of integrins (Burridge et al., 1997; Lawson et al.,
2012; Sieg et al., 1999), and eventually to the activation of various
signaling pathways by the small GTPases of the RAS superfamily.
These include RhoA, for stress ﬁber formation (reviewed by
Tojkander et al. (2012)), Rac, for lamellipodia/pseudopodia formation
(reviewed by Petrie and Yamada (2012)), and CDC42, for ﬁlopodia
formation (reviewed by Mattila and Lappalainen (2008)). All these
GTPases can stimulate elongation of actin ﬁlaments via their down-
stream targets to allow protrusion and forward movement of the cell
(reviewed by Le Clainche and Carlier (2008)).
One of the latest transformations to occur during tumorigenesis
is a switch from a non-migrating epithelial to a highly migrating
mesenchymal cellular phenotype (reviewed by Lamouille et al.
(2014) and Savagner (2010)), a process named epithelial–mesench-
ymal transition (EMT). During EMT, the downregulation of the
expression of the cell–cell junction protein E-cadherin (E-cad) and
an increase in FN and N-cadherin (N-cad) expression facilitate the
detachment and directed migration of individual cells. This is often
a sign of poor prognosis, as it allows primary tumors to reach the
blood vessels and spread throughout the organism, invading
secondary sites, and leading to cancer metastasis (reviewed by
Chaffer and Weinberg (2011) and Chiang and Massague (2008)).
Fig. 1. Time course of MVMp clustering. (A) Cells were grown on glass coverslips, incubated with MVMp at a MOI of 8 for 2 h at 4 1C, shifted to 37 1C for 0, 5, or 10 min, and
then prepared for IF microscopy. MVMp (red) was detected using a speciﬁc anti-capsid antibody. Actin ﬁlaments (pseudocolored in white) were labeled using AlexaFluor
647-conjugated phalloidin. Arrowheads point to MVMp clusters. (B) Quantiﬁcation of the number of MVMp clusters (bigger than 50 or 30 pixels for LA9 and PyMT cells
respectively) per cell for all the conditions from three independent experiments performed as described in A. Bar graphs show the mean7standard error of the mean;
n¼100; npo0.05; nnpo0.01, as determined by unpaired Student t-test. 00: 0 min; 50: 5 min; 100: 10 min. ND: not detectable.
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A variety of transforming agents can induce EMT, including the
polyomavirus middle T antigen (PyMT) and the transforming
growth factor β (TGF-β).
In this study, we addressed the mechanism involved in the
early stages of MVMp infection, and discuss whether this could
play a role in MVMp oncotropism. We show that MVMp clusters at
the leading edge of migrating LA9 mouse ﬁbroblasts and PyMT
mouse epithelial mammary tumor cells (derived from EMT
through PyMT transformation in transgenic mice (Granovsky
et al., 2000)), and that migrating cells are more susceptible than
non-motile cells to MVMp uptake. Moreover, we found that
promoting cell migration with an FN matrix increased MVMp
infection, and induction of EMT with TGF-β1 triggered MVMp
infection in rapidly dividing non-permissive epithelial cells. We
propose that the cell migration machinery represents another
determinant of MVMp infection and oncotropism.
Results
MVMp infection begins with the clustering of viral particles around
ﬁlopodia
Previous studies have indicated that some parvoviruses rely on
the formation of ﬁlopodia and α5β1-integrin activity to infect their
target cells (Linser et al., 1977; Weigel-Kelley et al., 2003); these two
cellular factors are also involved in cell migration. The fact that many
aggressive cancer cells migrate very rapidly could explain why some
parvoviruses infect certain tumor cells preferentially. Previously, EM
analysis showed that clusters of MVMp particles accumulated at
ﬁlopodia immediately prior to viral entry into LA9 cells (Linser et al.,
1977). We therefore designed experiments to visualize this viral
clustering at the plasma membrane prior to MVMp uptake in both
LA9 and PyMT cells. Cells were grown as monolayers, incubated with
MVMp at 4 1C for 2 h, and then at 37 1C for 0, 5, or 10 min (clustering
assay), before being prepared for immunoﬂuorescence (IF) micro-
scopy analysis. As shown in Fig. 1, clusters of MVMp were formed at
cell protrusions of both LA9 and PyMT cells after 5 min of incubation
at 37 1C. The MVMp clustering mechanism was temperature-depen-
dent, since these clusters were barely noticeable when cells were not
incubated at 37 1C after the initial 4 1C incubation period (Fig. 1,
panels labeled 00). The number of MVMp clusters in LA9 cells
increased with incubation at 37 1C from 5 min to 10 min (Fig. 2B).
This is in contrast to PyMT cells in which MVMp clustering peaked
after 5 min of incubation at 37 1C, and then decreased at 10 min
(Fig. 1B). This indicated that MVMp clustering occurred more rapidly
in PyMT than in LA9 cells. Thus, we chose to use 10 and 5 min
incubations at 37 1C for LA9 and PyMT cells, respectively, in subse-
quent clustering assays. Additionally, the MVMp clustering was
hampered when LA9 and PyMT cells were infected in the presence
of cytochalasin B (CytoB), indicating a requirement for actin poly-
merization in this viral clustering event (Fig. 2).
Next, we repeated the clustering assay in LA9 and PyMT cells,
but then prepared the cells for EM analysis. Ultrathin en-face
sections of cells (i.e., sections parallel to the cell monolayer) were
positively stained and observed using transmission EM. As shown
in Fig. 3, small groups of MVMp particles (5–10 particles) were
associated with ﬁlopodia, while bigger MVMp clusters (20–60
particles) were found to have accumulated at the base of ﬁlopodia
in both cell types. Pre-embedding immunogold labeling, using an
anti-MVMp capsid antibody, conﬁrmed that the observed clusters
were indeed MVMp particles (Fig. S1).
MVMp accumulates at the leading edge of migrating cells, which are
more susceptible to viral uptake
When assessing the results of the MVMp clustering assay in
both LA9 and PyMT cells by IF microscopy, we clearly noticed
Fig. 2. MVMp clustering depends on actin polymerization. (A) Cells were grown onto glass coverslips, assayed for MVMp clustering in the absence (Cont) or presence of
CytoB, and prepared for IF microscopy. MVMp (red) was detected with a speciﬁc anti-capsid antibody. Actin ﬁlaments (white) were detected using AlexaFluor 647-
conjugated phalloidin. Arrowheads point to MVMp clusters. (B) Quantiﬁcation of the number of viral clusters (bigger than 50 pixels) per cells for all the conditions from three
independent experiments performed as described in A. Bar graphs show the mean7standard error of the mean; n¼100; npo0.05; nnpo0.01, as determined by unpaired
Student t-test.
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MVMp clusters at the leading edge of both cell types, along
lamellipodial/pseudopodial structures (Fig. 4A). To conﬁrm this
observation, we repeated these experiments and immunolabeled
both MVMp and Arp 2/3 complex, which is a marker for the
leading edge of migrating cells (Suraneni et al., 2012). As expected,
we observed a close proximity of MVMp clusters to Arp 2/3
complexes in both cell types (Fig. 4B), which may indicate a role
of the cell migration process during the early stages of MVMp
infection.
In order to investigate the involvement of cell migration in the
early stages of MVMp infection further, we tested whether MVMp-
uptake increased in cells engaged in migration. For this experi-
ment, LA9 and PyMT cells were seeded at 100% conﬂuence onto
glass coverslips. Next, a wound was created, and the cells were
processed for an MVMp clustering assay, but were also tested for
viral uptake in the presence of baﬁlomycin A1 (bafA1). BafA1
inhibits the vacuolar Hþ-ATPase in the endosomal membrane that
is responsible for acidiﬁcation (Bayer et al., 1998), and thus arrests
MVMp in the early endosomes, which allows for better observa-
tion of virions entering the bafA1-treated cells. As illustrated in
Fig. 5, cells moving into the wound (migrating cells) displayed
higher levels of MVMp clustering and greater MVMp uptake at 4-h
post-infection than the non-migratory cells, in the case of both
LA9 and PyMT cells. These results indicated that cell migration
promotes efﬁcient MVMp clustering and uptake, which occur at
the leading edge of the cell.
MVMp infection increases with cell migration
Next, we tested whether promoting cell migration would
increase MVMp infection. LA9 and PyMT cells were seeded onto
glass coverslips coated with FN (a promoter of cell migration) or
with poly-L-lysine (poly-K, whose positive charge causes cells to
adhere tightly to the coverslips without stimulating cell motility), as
a control, and assayed MVMp infection (24 h infection at 37 1C at a
MOI of 4) by IF. In this experiment, the production of NS1 (the ﬁrst
Fig. 3. Electron micrographs of MVMp clustering at ﬁlopodia. Cells were assayed for MVMp clustering and prepared for EM. Images were acquired using a transmission EM
after en-face ultrathin sectioning (i.e., sectioning parallel to the cell monolayer) and positive staining. Panels A and B show electron micrographs of MVMp particles
accumulating at the base of ﬁlopodia from LA9 and PyMT cells respectively. Arrowheads point to areas that are enlarged in panels Z1 and Z2. FP indicates ﬁlopodia.
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Fig. 4. MVMp clusters at the leading edge of migrating cells. (A) Cells were assayed for MVMp clustering and prepared for IF microscopy. MVMp (red) was detected using a
speciﬁc anti-capsid antibody, and actin ﬁlaments (pseudocolored in white) were labeled with AlexaFluor 647-conjugated phalloidin. Arrowheads point to MVMp clusters.
Arrows point to lamellipodia at the leading edge of the cells. (B) Cells were assayed for MVMp clustering and processed as described in A. MVMp (red) and Arp 2/3 complex
(green) were detected using speciﬁc antibodies. Zoom shows high magniﬁcation images of areas marked with “Z”.
Fig. 5. MVMp clustering and uptake increase in migrating cells. Cells were grown to 100% conﬂuence, a wound was created and the cells were assayed for MVMp clustering
or uptake and processed for IF microscopy. MVMp (red) was detected using a speciﬁc antibody, AlexaFluor 647-conjugated phalloidin (pseudocolored in white) was used to
detect actin ﬁlaments, and DAPI (blue) was used to observe the nucleus. Arrowheads point to MVMp clusters. Images show half of a wound. The dotted lines indicate the
beginning of the wound.
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Fig. 6. MVMp infection increases with cell migration. (A) Cells were grown onto glass coverslips coated with 10 mg/ml FN or 0.01% poly-L-lysine (Poly-K), assayed for MVMp
uptake and prepared for IF microscopy. NS1 (magenta) was detected using a speciﬁc antibody. (B) Quantiﬁcation of MVMp in early endosomes from experiments performed
as described in B. Bar graphs show the mean7standard error of the mean; n¼1000; npo0.05; nnpo0.01, as determined by unpaired Student t-test.
Fig. 7. Epithelial–mesenchymal transition triggers MVMp infection. (A) Western blot analysis of EMT markers (E-cad and N-cad) of EpRas cells after 96 h incubation with or
without TGF-β1. (B) EpRas cells were induced for EMT, assayed for MVMp infection (48 h at 37 1C), and prepared for IF microscopy. The viral protein NS1 was detected with a
speciﬁc antibody, AlexaFluor 647-conjugated phalloidin (pseudocolored in white) was used to detect actin ﬁlaments, and DAPI (blue) was used to observe the nucleus.
(C) Quantiﬁcation of the percentage of NS1 positive cells from experiments performed as described in B. Bar graphs show the mean7standard error of the mean; n¼1000;
nnnpo0.005, as determined by unpaired Student t-test. (D) EpRas cells were induced for EMT, assayed for MVMp infection (48 h at 37 1C), and prepared for IF microscopy.
MVMp (red) was detected using a speciﬁc antibody, AlexaFluor 647-conjugated phalloidin (pseudocolored in white) was used to detect actin ﬁlaments, and DAPI (blue) was
used to observe the nucleus.
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viral protein to be expressed upon successful MVM infection, which
initiates viral DNA transcription (Doerig et al., 1990, 1988) and
which is therefore used as a measurement of MVM replication and
infection) was monitored to assess the onset of MVMp infection.
Wound healing assays ﬁrst conﬁrmed that the cells grown on
FN-coated surfaces migrated faster than those grown on poly-K-
coated surfaces, and also showed that PyMT cells migrated much
faster than LA9 cells (Fig. S2A and B). As illustrated in Fig. 6, LA9
cells grown on FN-coated coverslips showed a slightly higher
percentage (about 25%) of NS1-positive cells than LA9 cells grown
on a poly-K matrix, while the fraction of NS1-positive PyMT cells
was about 40% higher for cells grown on an FN matrix than for cells
grown on a poly-K matrix (Fig. 6B). Hence, it appeared that FN
promoted MVMp infection, particularly in PyMT cells.
To ensure that the reduced MVMp infection in LA9 and PyMT
cells grown on a poly-K matrix was not due to reduced cell
proliferation, given that MVMp requires cell entry into S-phase
to establish an infection (reviewed by Cotmore and Tattersall
(2006)), we performed cell proliferation assays with LA9 and
PyMT cells grown on poly-K- or FN-coated plastic dishes. This
experiment revealed that LA9 cells proliferated slightly faster on a
poly-K matrix than on an FN matrix, whereas the proliferation rate
of PyMT cells was similar for both conditions (Fig. S2C). Hence, the
increased MVMp infection observed with an FN matrix is not the
result of increased cell proliferation.
EMT triggers MVMp infection
One of the most common inducers of cancer cell migration is
EMT (reviewed by Lamouille et al. (2014) and Savagner (2010)).
Because we found that cell migration plays a role in the MVMp
infection, we next hypothesized that EMT could trigger MVMp
infection. To test this hypothesis, we used a model derived from
Ras-transformation of EpH4 mouse mammary epithelial cells
(EpRas, a model cell line that undergoes EMT upon exposure to
TGF-β (Oft et al., 1996)). EpRas cells were induced to undergo EMT
through a 96-h TGF-β1 treatment, and the success of EMT was
assessed by western blotting for E-cad and N-cad expression.
As shown in Fig. 7A, this treatment induced a partial reduction
of E-cad and an increase of N-cad expression in EpRas cells, even
though a proportion (about 50%) of the cells retained an epithelial
phenotype.
Next, we tested whether TGF-β1-induced EMT could affect
MVMp infection in EpRas cells, by detecting both NS1 and newly
produced virions. EpRas cells were ﬁrst treated with TGF-β1 as
described above, and then infected with MVMp (MOI of 8) at 37 1C
for 48 h; the time of infection was extended in this experiment, as
induction of EMT with TGF-β1 reduced cell proliferation. Cells
were then immunolabeled for NS1 or MVM capsid and investi-
gated by IF microscopy. As shown in Fig. 7B, EpRas cells showed no
sign of NS1 expression in the absence of TGF-β1 treatment, even
by 48-h post-infection. In contrast, induction of EMT allowed NS1
expression (Fig. 7B and C) and production of progeny virions
(Fig. 7D) in EpRas cells that had been infected with MVMp,
although only a limited number of cells could be infected (less
than 20%). This is likely because only a limited portion (maximum
50%) of EpRas cells actually underwent EMT (Fig. 7A). These
ﬁndings further highlighted that EMT and cell migration play a
role in MVMp infection, and potentially in MVMp oncotropism.
Lastly, since MVMp requires cell entry into S-phase to establish
infection (Cotmore and Tattersall, 2006), we assessed cell prolif-
eration of EpRas cells. The proliferation rate was considerably
higher in EpRas than in LA9 cells (Fig. S3), and thus the resistance
to MVMp infection observed in EpRas cells was not related to
reduced cell replication.
Discussion
The molecular mechanisms regulating MVMp oncotropism are
not completely understood. Previous studies have indicated that
several cellular factors and processes that occur late during MVMp
infection may contribute to MVMp oncotropism (reviewed by
Nuesch et al. (2012)). In this study, we investigated whether
events occurring early during the MVMp infection cycle may
contribute to MVMp infection and oncotropism, and found that
MVMp relies on various aspects of cell migration to infect its target
cells. Our combined EM and IF microscopy analysis revealed that
MVMp clusters in cell protrusions at the leading edge of migrating
LA9 and PyMT cells. We also found that cells engaged in migration
are more susceptible to MVMp uptake, and that promoting cell
migration on an FN matrix increases MVMp infection. Moreover,
we discovered that Ras-transformed epithelial cells were not
infected with MVMp, whereas inducing EMT on these cells
rendered them susceptible to MVMp infection.
We showed that binding of MVMp to the cell surface is rapidly
followed by clustering of the virus at the leading edge of migrating
cells, along cell protrusions, such as ﬁlopodia and lamellipodia/
pseudopodia. This mechanism was temperature-dependent
(Fig. 1), and required actin polymerization, since CytoB hampered
MVMp clustering in both LA9 and PyMT cells (Fig. 2). It has been
shown that short treatments (less than 1 h) with CytoB at low
concentrations (less than 10 mM) block the formation of cell
protrusions, without inducing marked cell detachment from the
coverslips or cell rounding, and prevent motile processes in
ﬁbroblast cells (Bliokh et al., 1980; Lin et al., 1978). Hence, our
results suggested that the formation of ﬁlopodia and lamellipodia/
pseudopodia at the leading edge of migrating cells promotes
MVMp clustering. Another explanation could be that the lateral
movement of MVMp receptors within the plasma membrane is
hampered at lower temperatures and requires actin polymeriza-
tion. Finally, the faster clustering of MVMp in PyMT cells than in
LA9 cells (Fig. 1) may be related to the enhanced migration kinetics
of PyMT cells (Fig. S2A and B).
Both our IF and EM analysis results clearly demonstrate an
association of groups of MVMp particles with ﬁlopodia in both LA9
and PyMT cells. Similarly, canine parvovirus binds to ﬁlopodia of
canine cells in clusters of several virions, which then accumulate
at the base of ﬁlopodia already at 5-min post-infection (Harbison
et al., 2009). Other viruses have also been observed to associate
with cell protrusions. For example, Semliki Forest virus binds to
microvilli before entering cells via endocytosis (Helenius et al.,
1980). More recently, using single-particle imaging and ﬂuores-
cently labeled viruses it has been documented that viruses, such as
murine leukemia virus (Lehmann et al., 2005), human papilloma-
virus type 16 (Schelhaas et al., 2008), vaccinia virus (Mercer and
Helenius, 2008), adenovirus type 2 (Burckhardt and Greber, 2009),
and herpes simplex virus type 1 (Oh et al., 2010), interact with
ﬁlopodia and move (or “surf”) down these protrusions to reach the
cell body during entry into their target cells. While some of these
viruses surf down ﬁlopodia as single particles, MVMp may move
down ﬁlopodia as clusters comprising a few virions, because we
observed large clusters at the tips of ﬁlopodia (Fig. 1).
While some viruses rely on formation of ﬁlopodia to establish
infection, other viruses induce ﬁlopodia formation. For example,
cells respond to herpes simplex virus type 1 infection by enhanced
ﬁlopodia formation (Oh et al., 2010), while high titers of adeno-
associated virus type 2 trigger ﬁlopodia formation to allow viral
endocytosis (Nonnenmacher and Weber, 2011). However, unlike
these viruses, MVMp does not seem to induce the formation of
ﬁlopodia, because there was no difference in the number/appear-
ance of ﬁlopodial extensions in the absence/presence of MVMp,
even at high virus concentrations. Instead, it appears that, during
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MVMp infection, the virus depends on these structures for
clustering before entering into the cell.
We next showed that LA9 and PyMT cells that migrate during
wound healing are more susceptible to MVMp clustering and
uptake (Fig. 4). This further supported the concept that directed
cell migration and formation of cell protrusions facilitate the early
events of MVMp infection, since MVMp uptake was limited in cells
located far away from the wound, which have no leading edge and
which are barely able to form protrusions. Consistent with these
ﬁndings, promoting LA9 and PyMT cell migration on an FN matrix
increased MVMp infection in comparison to that seen in cells
grown on a poly-K matrix (Fig. 6). An explanation for this
phenomenon is that, in some of the early stages of MVMp
infection the signaling activity that takes place at the leading edge
of migrating cells is essential, and this involves endocytosis of
plasma membrane receptors for degradation in lysosomes in an
FN-dependent manner.
However, the effect of the FN matrix was rather limited in LA9
cells, potentially because these are ﬁbroblasts that secrete FN
constitutively. In contrast, MVMp infection was more reduced in
PyMT cells grown on a poly-K compared to an FN matrix. It is now
well accepted that the ability of MVMp to reach the nucleus is
directly dependent on both endosomal acidiﬁcation, to escape late
endosomes (Mani et al., 2006), and the ubiquitin/proteasome
system (Ros and Kempf, 2004). Hence, it is possible that the ability
of FN to induce ubiquitination and lysosomal degradation of cell
surface receptors during cell migration (Lobert et al., 2010) pro-
motes MVMp infection. It is also possible that MVMp simply hijacks
the FN degradation pathway to its own advantage, since a portion of
extracellular FN is internalized by endocytosis and is degraded in
the lysosome during cell migration (Lobert et al., 2010).
Finally, we demonstrated that induction of EMT in EpRas cells
by TGF-β1 treatment rendered these cells susceptible to MVMp
infection (Fig. 7). Although TGF-β1 triggers a complex signaling
pathway and any of the proteins involved in this pathway may be
directly involved in the mechanism of MVMp uptake and infection,
our results of the TGF-β1-induced EMT experiment conﬁrm our
conclusions that mesenchymal cell migration is a factor contribut-
ing to MVMp infection. We demonstrated that this is true for
several models of tissue cultured cells used in this study; however,
it remains to be determined whether cell migration and its
associated parameters play a role in the infection of MVMp in
animal models.
In summary, the results presented here demonstrate that cell
migration inﬂuences MVMp infection. To our knowledge, this is
the ﬁrst demonstration of a virus relying on such a mechanism.
Cell migration is a key factor in many cases of aggressive and
metastatic cancers; thus, it is possible that the hijacking of the cell
migration machinery by MVMp can partially explain its intriguing
oncotropic properties.
Materials and methods
Cell culture and virus production
LA9 and PyMT cells were maintained at 5% CO2 and 37 1C in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 1% glutamine, and penicillin–
streptomycin. EpRas cells were maintained at 5% CO2 and 37 1C
in DMEM F12 supplemented with 5% FBS, 1% glutamine, and 5
mg/ml insulin. MVMp was produced and puriﬁed based on the
procedures described by Tattersall et al. (1976) and Williams et al.
(2004) with an extended step of dialysis to completely remove
cesium chloride. The yield was assessed by plaque assay to be
2.1109 plaque-forming units per milliliter (pfu/ml).
Antibodies and reagents
Mouse antibody against the intact MVMp capsid (Kaufmann
et al., 2007) and mouse antibody against NS1 (Yeung et al., 1991)
were a generous gift from Dr. P. Tattersall (Yale School of
Medicine). Rabbit Arp 2/3 complex (ab47654), clathrin (ab59710),
and N-cadherin (ab18203) antibodies were purchased from
Abcam. Mouse E-cadherin (610182) antibody was purchased from
BD laboratories. AlexaFluor 647-conjugated phalloidin was pur-
chased from Invitrogen. FITC-phalloidin, cytochalasin B (C-6762)
and baﬁlomycin A1 (B1793) were purchased from Sigma. Alexa-
Fluor 647- and 549-conjugated secondary antibodies were pur-
chased from Jackson ImmunoResearch laboratories. DAPI Prolong
Gold Antifade was purchased from Life technologies.
MVMp clustering assay
Cells grown as monolayers at about 50% conﬂuence were
incubated with MVMp (MOI of 8) in infection medium (IM: DMEM
containing 1% glutamine) for 15 min at 4 1C. Next, the virus-
containing medium was replaced with fresh IM, the cells were
incubated at 4 1C for 2 h, switched to 37 1C for 0, 5, or 10 min, and
then prepared for IF microscopy as indicated below. MVMp was
detected with a speciﬁc anti-capsid antibody, and actin ﬁlaments
were labeled using AlexaFluor 647-conjugated phalloidin. For the
clustering assay in the presence of CytoB, the cells were incubated
with 4 mM CytoB for 30 min at 37 1C before processing for MVMp
clustering assay (in the presence of 4 mM CytoB). In the case of the
clustering assay during wound healing, the cells were seeded at
100% conﬂuence, a wound was created using a 100 ml tip, the cells
were allowed to recover for about 3 h, and then processed for
clustering assay.
MVMp uptake assay
Cells grown as monolayers at about 50% conﬂuence were
incubated with IM containing 100 nM bafA1 for 1 h at 37 1C, and
then with MVMp (MOI of 8) in IM for 15 min at 4 1C. The virus-
containing mediumwas replaced with fresh IM containing 100 nM
bafA1, the cells were incubated for 4 h at 37 1C and 5% CO2, and
then prepared for IF microscopy as indicated below. MVMp was
detected with a speciﬁc anti-capsid antibody, actin ﬁlaments were
labeled using AlexaFluor 647-conjugated phalloidin, and the
nucleus of the cells was detected with DAPI. In the case of the
uptake assay during wound healing, the cells were seeded at 100%
conﬂuence, a wound was created using a 100 ml tip, the cells were
allowed to recover for about 3 h, and then processed for the
uptake assay.
MVMp infection assay
Cell grown as monolayers at about 50% conﬂuence were
incubated with MVMp (MOI of 8) for 15 min at 4 1C in IM. The
virus-containing medium was then replaced with fresh IM, the
cells were incubated for 24 h (or 48 h in the case of the cells
induced for EMT) at 37 1C and prepared for IF microscopy or
western blot as indicated below. MVMp and NS1 were detected
using speciﬁc antibodies.
Induction of epithelial–mesenchymal transition
EpRas cells were seeded onto plastic dishes coated with 10 mg/
ml FN and treated with 10 ng/ml TGF-β1 for 72 h. The cells were
then detached with trypsin and reseeded, in order to decrease the
conﬂuence and allow even spreading of the cells, onto glass
coverslips (for IF) or plastic dishes (for western blot) coated with
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10 mg/ml FN, for subsequent infection with MVMp or western blot
analysis of EMT markers.
Immunoﬂuorescence (IF) microscopy
Cells grown on glass coverslips and assayed as indicated above
were rinsed once with PBS, ﬁxed with 4% paraformaldehyde (PFA)
in water for 10 min at 4 1C, permeabilized with 0.2% Triton X-100
in PBS containing 2.5% BSA for 2 min at room temperature (RT),
and blocked with PBS containing 2.5% BSA for 30 min at RT. Cells
were incubated with primary antibodies for 1 h at RT, washed with
PBS containing 2.5% BSA, and then incubated with ﬂuorescently-
labeled secondary antibodies for 20 min at RT. For some experi-
ments actin was labeled with 1 mg/ml AlexaFluor 647-conjugated
phalloidin for 20 min at RT. Cells were rinsed several times with
PBS containing 2.5% BSA and mounted using Prolong Gold Anti-
fade with DAPI.
Confocal microscopy and image analysis
All IF images shown here were acquired using a Fluoview 1000
confocal laser-scanning microscope (Olympus). Images of single
cells were obtained with a 100 plan apochromatic objective
(pinhole 185 mm). The low magniﬁcation images were obtained
with a 60 plan apochromatic (pinhole 150 mm). For the cluster-
ing assay, images were acquired in the plane of focal contacts, and
viral clusters bigger than 50 or 30 pixels (for LA9 or PyMT cells
respectively, since different magniﬁcations were used for imaging
these cells) were counted using ImageProPlus. For the uptake
assay, images were acquired in the plane of the nucleus. All the
ﬂuorescence images shown are representative of three indepen-
dent experiments, and values are given as the mean of triplica-
tes7standard deviation. Statistical signiﬁcance was determined
by unpaired Student's t test. All ﬂuorescence quantiﬁcation
was determined from images obtained from three independent
experiments.
Electron microscopy
About 60% conﬂuent cell monolayers grown on Aclar ﬁlms
(Pelco) was assayed for MVMp clustering as indicated above, but
the cells were incubated with MVMp at a MOI of 32. The cells were
then washed in PBS, ﬁxed with 4% glutharaldehyde in 0.1 M
sodium cacodylate for 1 h at 4 1C, post-ﬁxed with 1% OsO4 in
0.1 M sodium cacodylate for 1 h at 4 1C, and stained en bloc with
1% uranyl acetate. Cells were then dehydrated and embedded in
Epon. Ultrathin sections resulting from en-face (i.e., sections
parallel to the cell monolayer) were positively stained with 2%
uranyl acetate and 2% lead citrate. Images were acquired using a
FEI Tecnai G2 transmission electron microscope operated at an
acceleration voltage of 120 kV. Micrographs were digitally
recorded using an Eagle 4k CCD camera (FEI). All the EM images
showed are representative of three independent experiments.
Western blot
Cells were washed with ice-cold PBS, scrapped, centrifuged for
4 min at 1000 g, resuspended in lysis buffer (20 mM Tris–HCl, pH
7.6, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, and 3 mM EGTA,
containing freshly added 2 mM DTT, 0.5 mM PMSF, 1 mM sodium
vanadate, 2.5 mM sodium ﬂuoride, and 1 μM leupeptin) for
30 min at 4 1C, and then centrifugated for 4 min at 5000 g. The
supernatants were subsequently stored at 20 1C. Protein con-
centrations of the cell lysates were determined by Bradford assay.
10 mg total cell lysates was diluted in sample buffer (50 mM Tris-
base pH 6.8, 2% SDS, 10% glycerol, 1% β-mercaptoethanol, and
0.02% bromophenol blue), run through a 10% SDS-PAGE for 1 h at
160 V, and transferred to nitrocellulose membrane by semi-dry
transfer for 1 h at 20 V. Membranes were blocked with PBS
containing 0.1% Tween 20 and 5% skim milk, followed by overnight
incubation with either E-cad (dilution 1:5000) or N-cad (dilution
1:1000) primary antibodies diluted in PBS containing 0.5% Tween
20 and 0.25% skim milk. After three washes in PBS containing 0.5%
Tween 20, the membranes were incubated overnight with HRP-
conjugated secondary antibodies. After three washes in PBS con-
taining 0.5% Tween 20, the antibodies were detected using an
enhanced chemiluminescent kit (GE healthcare).
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